申请人:Wunberg Tobias
公开号:US20110098275A1
公开(公告)日:2011-04-28
The present invention encompasses compounds of general formula (1)
wherein
R
1
to R
4
, m and n are defined as in the specification, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了通式(1)中定义的化合物,其中R1至R4,m和n如规范中所定义,适用于治疗由过度或异常细胞增殖特征的疾病,并且可以用于制备具有上述特性的药物。